Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
12/1998
12/17/1998WO1998056896A1 Method of attenuating viruses
12/17/1998WO1998039467A3 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof
12/17/1998WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
12/17/1998CA2263993A1 Method of attenuating viruses
12/16/1998EP0884383A1 Method of purifying and removing viruses
12/16/1998EP0884382A2 Processes for preparation of marek's disease virus using continuous mammalian cell lines
12/15/1998US5849994 Animal model for HIV-1 induced disease
12/15/1998US5849870 Pesticidal proteins and strains
12/15/1998US5849586 Infective protein delivery system
12/15/1998US5849561 Method for the production of non-group C adenoviral vectors
12/15/1998US5849548 Cell ablation using trans-splicing ribozymes
12/15/1998US5849476 Recombinant varicella-zoster virus and process for constructing same
12/15/1998US5849304 Recombinant vaccinia virus expressing human retrovirus gene
12/15/1998CA2091886C Multiple promoter baculovirus expression system and defective particle production
12/15/1998CA1340243C Recombinant marek's disease virus and a vaccine
12/15/1998CA1340211C A method of inactivating a lipid-enveloped virus in a therapeutic solution
12/10/1998WO1998055641A2 Somatic gene therapy to suppress secondary cataract formation
12/10/1998WO1998055640A1 Retroviral vector particles produced in a baculovirus expression system
12/10/1998WO1998055626A2 Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
12/10/1998WO1998039465A3 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
12/10/1998CA2289491A1 Retroviral vector particles produced in a baculovirus expression system
12/10/1998CA2234423A1 Processes for preparation of marek's disease virus using continuous mammalian cell lines
12/09/1998EP0882455A1 Virus-inactivated blood product
12/09/1998EP0882134A1 Methods and compositions for protective and therapeutic genetic immunization
12/09/1998EP0882130A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
12/09/1998EP0882060A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof
12/09/1998EP0881913A1 Liposomal-viral dna complexes for treating disease
12/09/1998EP0566579B1 Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and compositions
12/09/1998CN1201071A Counter virus-gene transfer carrier PLJF and preparation method thereof
12/08/1998US5847096 DNA constructs encoding CD4 fusion proteins
12/08/1998US5846945 Cytopathic viruses for therapy and prophylaxis of neoplasia
12/08/1998US5846825 Feline derived T-cell lines for producing FIV
12/08/1998US5846806 Identification of a human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression
12/08/1998US5846805 Culture of swine infertility and respiratory syndrome virus in simian cells
12/08/1998US5846707 Herpes simplex virus as a vector
12/08/1998US5846546 Preparation and use of viral vectors for mixed envelope protein immunogenic composition against human immunodeficiency viruses
12/08/1998US5846538 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
12/08/1998US5846527 Continuous cell line and vaccine against avian coccidia
12/03/1998WO1998054346A1 Alternatively targeted adenovirus
12/03/1998WO1998054322A1 Osf2/cbfa1 compositions and methods of use
12/03/1998CA2291698A1 Osf2/cbfa1 compositions and methods of use
12/03/1998CA2291323A1 Alternatively targeted adenovirus
12/02/1998EP0527839B1 Recombinant library screening methods
12/02/1998CN1200675A 流感疫苗 Influenza vaccination
12/01/1998US5843775 Human dorsal tissue affecting factor (noggin) and nucleic acids encoding same
12/01/1998US5843733 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
12/01/1998US5843637 Methods for identifying non-essential genes of the human cytomegalovirus genome and for screening for inhibitors of human cytomegalovirus
12/01/1998US5843458 Recombinant human cytomegalovirus having a US2 deletion
12/01/1998US5843456 Alvac poxvirus-rabies compositions and combination compositions and uses
12/01/1998US5843429 Gonad-specific virus which causes sterility in the corn earworm, Helicoverpa zea
12/01/1998CA2042494C Photodynamic inactivation of viruses in cell-containing compositions
12/01/1998CA1340157C Hiv peptides and methods for detection of hiv
11/1998
11/26/1998WO1998053087A1 Method for the production of non-group c adenoviral vectors
11/26/1998WO1998053078A1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
11/26/1998WO1998052964A1 Rupestris stem pitting associated virus nucleic acids, proteins, and their uses
11/26/1998CA2291216A1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
11/26/1998CA2290779A1 Rupestris stem pitting associated virus nucleic acids, proteins, and their uses
11/25/1998EP0879284A1 Gene expression vectors which generate an antigen specific immune response and methods of using the same
11/25/1998EP0879055A1 Inhibition of viral replication
11/25/1998EP0592636B1 Process for the production of a viable cell culture infected by a multiple sclerosis associated virus
11/25/1998EP0486562B1 Mutant pseudorabies virus, and vaccines containing the same
11/25/1998CN1200148A Methods for enhancing the production of viral vaccines in cell culture by interferon suppression
11/24/1998US5840868 Pesticidal proteins and strains
11/24/1998US5840839 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
11/24/1998US5840695 Ectoparasite saliva proteins and apparatus to collect such proteins
11/24/1998US5840565 Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
11/24/1998US5840563 Method for growing swine infertility and respiratory syndrome virus
11/24/1998US5840541 Recombinant molecule comprising the polyhedrin gene promoter of baculovirus and a structural gene of a rotovirus; biosynthesis of antigenic protein ns28; use in vaccines, viral detection
11/24/1998US5840526 Two heavy polypeptide chains with variable and constant regions including complete antigen binding sites; constant region lacks ch1 domain; increased ease of preparation by genetic engineering; medical diagnosis
11/24/1998US5840520 Recombinant negative strand RNA virus expression systems
11/24/1998US5840480 Retrovirus from the HIV group and its use
11/19/1998WO1998051810A1 Lentivirus-based gene transfer vectors
11/19/1998WO1998051808A1 Methods for producing retroviral vectors with an altered tropism
11/19/1998WO1998051700A1 Retroviral envelopes having modified hypervariable polyproline regions
11/19/1998WO1998051660A1 Methods and compositions for the selective modification of nucleic acids
11/19/1998WO1998051327A1 Therapeutic agent, treatment method, prophylactic agent, and prophylactic method for canine and feline immunological diseases
11/19/1998WO1998034640A3 Synthetic hiv gag genes
11/19/1998CA2289953A1 Methods for producing retroviral vectors with an altered tropism
11/19/1998CA2289619A1 Methods and compositions for the selective modification of nucleic acids
11/19/1998CA2288328A1 Lentivirus-based gene transfer vectors
11/18/1998EP0878547A1 Methods for producing retroviruses with an altered tropism
11/18/1998EP0877752A1 Methods for screening for transdominant effector peptides and rna molecules
11/18/1998EP0690990B1 Parvovirus receptors and methods of use
11/18/1998CN1199419A Method for purifying viruses by chromatography
11/17/1998US5837532 Herpes simplex cirus type 1 mutant
11/17/1998US5837531 Recombinant adenoviruses for gene therapy in cancers
11/17/1998US5837520 Method of purification of viral vectors
11/17/1998US5837500 Gene expression; genetic engineering; mutation
11/17/1998US5837484 Stable cell lines capable of expressing the adeno-associated virus replication gene
11/17/1998US5837260 Killing hepatitis virus
11/17/1998US5837248 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
11/16/1998CA2205677A1 Novel replication process
11/12/1998WO1998050573A1 Isolated melanin-like substance and method for producing the same
11/12/1998WO1998050571A1 Entomopoxvirus-based gene delivery vector for vertebrates
11/12/1998WO1998050529A1 Attenuation of negative stranded rna viruses by rearrangement of their genes and uses thereof
11/12/1998WO1998050522A1 Method and apparatus for high volume production of viral particles
11/12/1998WO1998050405A1 An infectious clone for human parainfluenza virus type 3
11/12/1998WO1998050070A1 Live virus vaccines to protect primates from hiv-1 infection and disease
11/11/1998EP0877086A2 Recombinant YF virus vaccines recovered from the infectious cDNA
11/11/1998EP0876498A1 Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv
1 ... 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 ... 267